These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14250912)

  • 1. [ANTILIPEMIC EFFECT OF ACID SODIUM HEPARIN AFTER SUBLINGUAL OR RECTAL ADMINISTRATION].
    SCHOELL H; KOPITZKI F
    Klin Wochenschr; 1964 Jul; 42():699-707. PubMed ID: 14250912
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of lipemia-clearing activity after sublingual administration of heparin potassium in the rabbit.
    MANGIERI CN; CAIN RA
    Angiology; 1961 Apr; 12():136-8. PubMed ID: 13766149
    [No Abstract]   [Full Text] [Related]  

  • 3. AN INVESTIGATION OF ROUTES OF ADMINISTRATION OF HEPARIN OTHER THAN INJECTION.
    WINDSOR E; FREEMAN L
    Am J Med; 1964 Sep; 37():408-16. PubMed ID: 14209287
    [No Abstract]   [Full Text] [Related]  

  • 4. [METHODS OF EVALUATING ANTILIPEMIC ACTION IN VIVO AND IN VITRO IN RATS].
    HORNACEK J; HLADOVEC J; KRPATOVA J
    Cas Lek Cesk; 1963 May; 102():641-4. PubMed ID: 14077274
    [No Abstract]   [Full Text] [Related]  

  • 5. SUBLINGUAL HEPARIN; THE INABILITY TO DETECT LIPID-CLEARING OR ANTICOAGULANT EFFECTS OF HIGH DOSES.
    SPUDIS EV; HUTAFF LW; MILLER HS; LOFLAND H
    Neurology; 1965 May; 15():486-90. PubMed ID: 14288641
    [No Abstract]   [Full Text] [Related]  

  • 6. LIPID METABOLISM AND THE LAYING HEN. 3. PLASMA LIPOPROTEIN LIPASE IN RELATION TO THE ONSET OF LAYING.
    HEALD PJ; FURNIVAL BM; ROOKLEDGE KA
    Biochim Biophys Acta; 1965 Feb; 98():66-72. PubMed ID: 14290840
    [No Abstract]   [Full Text] [Related]  

  • 7. DETERMINATION OF HEPARIN-INDUCED LIPOPROTEIN LIPASE ACTIVITY IN HUMAN PLASMA.
    BOBERG J; CARLSON LA
    Clin Chim Acta; 1964 Nov; 10():420-7. PubMed ID: 14230938
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antilipemic effect of heparin. II. Changes of lipid concentration and lipase activity; problems of the reversibility of heparin action].
    GERO S; ROHNY B; GACS J
    Magy Belorv Arch (1955); 1958 Feb; 11(1):29-33. PubMed ID: 13551235
    [No Abstract]   [Full Text] [Related]  

  • 9. [On a biological test for antilipemic derivatives of heparin].
    HERBAIN M
    Clin Chim Acta; 1960 Mar; 5():204-7. PubMed ID: 14401197
    [No Abstract]   [Full Text] [Related]  

  • 10. THE EFFECT OF HEPARIN PRETREATMENT ON DEVELOPMENT AND CLEARING OF ALIMENTARY LIPEMIA.
    Barboriak JJ; Kory RC; Chamilton LH
    Am J Clin Nutr; 1965 May; 16():412-6. PubMed ID: 14286798
    [No Abstract]   [Full Text] [Related]  

  • 11. LIPOLYTIC ACTIVITY IN THE BLOOD AFTER LIPASE INGESTION.
    TIDWELL HC; MCPHERSON JC; MOORE WT; POPE JL; FREEMAN A
    Proc Soc Exp Biol Med; 1964 Jul; 116():720-3. PubMed ID: 14194643
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the antilipemic and anticoagulant activity of a heparin derivative].
    REGAZZINI A; RODARI T
    Rass Fisiopatol Clin Ter; 1961 Apr; 33():301-16. PubMed ID: 14491056
    [No Abstract]   [Full Text] [Related]  

  • 13. HEPARIN AND THE ELECTROPHORETIC MOBILITY OF BETA-LIPOPROTEIN IN CORONARY DISEASE.
    GROVER ME
    Am J Cardiol; 1965 Jan; 15():13-6. PubMed ID: 14248273
    [No Abstract]   [Full Text] [Related]  

  • 14. LIPOIDS IN THE GENESIS OF ATHEROSCLEROSIS.
    WATSON JH
    South Med J; 1964 May; 57():507-8. PubMed ID: 14143423
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative study of various drugs and their action on lipids and the clearing factor].
    MOSSO HE; PERGOLA F; KATZ S
    Dia Med; 1962 Mar; 34():330-4. PubMed ID: 14476562
    [No Abstract]   [Full Text] [Related]  

  • 16. HEPARIN AND THE REMOVAL OF TRIGLYCERIDE FROM THE BLOOD STREAM.
    ENGELBERG H
    Am J Cardiol; 1964 Jul; 14():8-17. PubMed ID: 14176898
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECT OF SUBLINGUAL POTASSIUM HEPARIN (CLARIN) ON THE SERUM LIPASE ACTIVITY OF PATIENTS FOLLOWING FRACTURES.
    ADLER F; PELTIER LF
    J Trauma; 1964 May; 4():390-3. PubMed ID: 14170160
    [No Abstract]   [Full Text] [Related]  

  • 18. POST-HEPARIN LIPOLYTIC ACTIVITY FOLLOWING INTRAVENOUS HEPARIN-S35.
    PORTE D; WILLIAMS RH
    Proc Soc Exp Biol Med; 1965 Mar; 118():639-43. PubMed ID: 14264516
    [No Abstract]   [Full Text] [Related]  

  • 19. DEFICIENT ABSORPTION OF BUCALLY ADMINISTERED HEPARIN.
    HARTMANN G; STAUB H
    Vasc Dis; 1964 Jul; 1():173-9. PubMed ID: 14192705
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES OF THE INFLUENCE OF DIET ON CLEARING-FACTOR LIPASE (CFL) AND BLOOD LIPID LEVELS OF A PATIENT WITH HYPERLIPIDEMIA.
    MACNAB M; MACMILLAN RL; MONKHOUSE FC
    Can Med Assoc J; 1965 Jan; 92(5):217-20. PubMed ID: 14246294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.